Skip to main content
Clinical Trials/ACTRN12620000143921
ACTRN12620000143921
Not yet recruiting
未知

A pilot randomized controlled trial assessing the gastrointestinal tolerability and health benefits of Soluble Tapioca Fibre in adults with healthy gastrointestinal systems: Phase Two

Murdoch University0 sites60 target enrollmentFebruary 12, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Murdoch University
Enrollment
60
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2020
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Individuals without clinically diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility and agree to keep a detailed dietary for GI symptoms and stool characteristics during the study. In addition, potential participants will be required to complete Phase One of the study to be eligible for participation in Phase Two of the study.

Exclusion Criteria

  • Individuals having constipation, defined as 0–3 stools per week for the last 6 weeks; prescription of medication for digestive symptoms such as anti\-spasmodic, laxatives, anti\-diarrheic drugs or other digestive auxiliaries, relevant history/presence of any medical disorder or intake of medication/dietary supplements potentially interfering with this trial (e.g. irritable bowel syndrome), vegetarians or vegans, intake of antibiotics within 4 weeks before the screening visit and intake of laxatives within 2 weeks before the screening visit.

Outcomes

Primary Outcomes

Not specified

Similar Trials